History

STRI was all about turning the future into a reality that bears greater meaning for all mankind. Now we stand at a critical turning point where our simple but meaningful discovery is turning into the tangible and this is becoming possible thanks to the many collaborators who are looking forward together with us.

  • 2018

    -Registered newly Elicited Pluripotent Stem Cells without side effects (nEPS) 30 registered and about 670 related patents applied in Korea, Singapore, Austrailia, Russia, and United States of America.

  • 2016

    -Pre-clinical using hepatocyte (for Korea) with Seoul National Univ. Bundang Hospital

  • 2015

    -Registered newly Elicited Pluripotent Stem Cells without side effects (nEPS) 16 registered and 94 related patents applied in 146 countries

  • 2014

    -Differentiated nEPS cells into six different organ cells – pancreatic beta cells, neurocytes, hepatocytes, adipocytes, osteoblasts and chondrocytes

  • 2013

    -Discovered world’s first newly Elicited Pluripotent Stem Cells without side effects (nEPS)

  • 2007

    -Research arm expands into the Stem Cell Treatment & Research Institute

  • 2000

    -STRI Fundamental Sciences Department launches with 3 sub-divisions
    -STRI Life Sciences Research Center receives Korea Industrial Technology Association (KOITA) certification
    -STRI Agricultural Life Sciences Research Center completes Plant Products Manufacturing Plant

  • 1999

    -Renamed as the STRI Stem Cell Research Institute

  • 1997

    -STC Nara opens manufacturing plant in Cheonan

  • 1995

    -Established STC Agricultural Life Sciences Research Center

  • 1992

    -STC Nara, responsible for research, development and manufacturing life sciences based cosmetics and health supplements is launched

  • 1989

    -Established STC Life Sciences Research Center (with the core values of Soul, Treatment & Cell
    to contribute to mankind by developing stem cell based therapy with a righteous mind.)